tiprankstipranks
Trending News
More News >
Novo Integrated Sciences (NVOS)
OTHER OTC:NVOS
US Market

Novo Integrated Sciences (NVOS) Stock Statistics & Valuation Metrics

Compare
247 Followers

Total Valuation

Novo Integrated Sciences has a market cap or net worth of $13.81K. The enterprise value is .
Market Cap$13.81K
Enterprise Value

Share Statistics

Novo Integrated Sciences has 19.73M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19.73M
Owened by Insiders0.04%
Owened by Instutions0.07%

Financial Efficiency

Novo Integrated Sciences’s return on equity (ROE) is -1.08 and return on invested capital (ROIC) is -48.63%.
Return on Equity (ROE)-108.30%
Return on Assets (ROA)-50.18%
Return on Invested Capital (ROIC)-48.63%
Return on Capital Employed (ROCE)-57.38%
Revenue Per Employee$117,538.765
Profits Per Employee-$211,555.026
Employee Count115
Asset Turnover0.41
Inventory Turnover7.55

Valuation Ratios

The current PE Ratio of Novo Integrated Sciences is -0.35. Novo Integrated Sciences’s PEG ratio is 0.01.
PE Ratio-0.35
PS Ratio0.43
PB Ratio0.38
Price to Fair Value0.38
Price to FCF-2.48
Price to Operating Cash Flow-2.53
PEG Ratio0.01

Income Statement

In the last 12 months, Novo Integrated Sciences had revenue of $13.52M and earned -$24.33M in profits. Earnings per share was -$1.38.
Revenue$13.52M
Gross Profit$5.09M
Operating Income-$10.47M
Pretax Income-$24.34M
Net Income-$24.33M
EBITDA-16.02M
Earnings Per Share (EPS)-1.38

Cash Flow

In the last 12 months, operating cash flow was -$4.75M and capital expenditures -$30.35K, giving a free cash flow of -$4.79M billion.
Operating Cash Flow-$4.75M
Free Cash Flow-$4.79M
Free Cash Flow per Share-$0.24

Dividends & Yields

Novo Integrated Sciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-40.40%
Earnings Yield-284.22%

Stock Price Statistics

Beta-4.26
52-Week Price Change-89.13%
50-Day Moving Average0.06
200-Day Moving Average0.29
Relative Strength Index (RSI)42.43
Average Volume (3m)49.12K

Important Dates

Novo Integrated Sciences upcoming earnings date is Jul 10, 2025, After Close.
Last Earnings DateApr 9, 2025
Next Earnings DateJul 10, 2025
Ex-Dividend Date

Financial Position

Novo Integrated Sciences as a current ratio of 0.37, with Debt / Equity ratio of 0.32
Current Ratio0.37
Quick Ratio0.30
Debt to Market Cap0.83
Net Debt to EBITDA-0.38
Interest Coverage Ratio15.45

Taxes

In the past 12 months, Novo Integrated Sciences has paid $2.59M in taxes.
Income Tax$2.59M
Effective Tax Rate0.00%

Enterprise Valuation

Novo Integrated Sciences EV to EBITDA ratio is -0.95, with an EV/FCF ratio of -4.16.
EV to Sales0.72
EV to EBITDA-0.95
EV to Free Cash Flow-4.16
EV to Operating Cash Flow-4.25

Balance Sheet

Novo Integrated Sciences has $1.54M in cash and marketable securities with $4.50M in debt, giving a net cash position of $2.96M billion.
Cash & Marketable Securities$1.54M
Total Debt$4.50M
Net Cash$2.96M
Net Cash Per Share$0.15
Tangible Book Value Per Share-$0.29

Margins

Gross margin is 43.20%, with operating margin of -75.79%, and net profit margin of -121.32%.
Gross Margin43.20%
Operating Margin-75.79%
Pretax Margin-121.32%
Net Profit Margin-121.32%
EBITDA Margin-75.79%
EBIT Margin-126.23%

Analyst Forecast

The average price target for Novo Integrated Sciences is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast5.75%
EPS Growth Forecast55.68%

Scores

Smart Score
AI Score34
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis